Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIROFIBAN vs TIRZEPATIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TIROFIBAN vs TIRZEPATIDE: Safety Overview

Metric TIROFIBAN TIRZEPATIDE
Total FAERS Reports 2,166 99,893
Deaths Reported 232 455
Death Rate 10.7% 0.5%
Hospitalizations 185 5,527
Average Patient Age 61.8 yrs 53.9 yrs
% Female Patients 48.1% 75.6%
FDA Approval Date Apr 20, 2000 Jan 20, 2026
Manufacturer Medicure International Inc Eli Lilly and Company
Route INTRAVENOUS N/A
Marketing Status Discontinued Prescription